- Home
- TWIN vs INBX Comparison
TWIN vs INBX Comparison
Compare TWIN & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWIN | INBX |
|---|---|---|
| Founded | 1918 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.9M | 1.5B |
| IPO Year | 1994 | 2024 |
Fundamental Metrics
Financial Performance| Metric | TWIN | INBX |
|---|---|---|
| Price | $24.48 | $110.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $150.00 |
| AVG Volume (30 Days) | 94.3K | ★ 317.9K |
| Earning Date | 05-06-2026 | 05-15-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | ★ 1428.57 | N/A |
| EPS | ★ 1.86 | N/A |
| Revenue | ★ $381,270,000.00 | $1,300,000.00 |
| Revenue This Year | $10.79 | N/A |
| Revenue Next Year | $8.43 | N/A |
| P/E Ratio | $13.26 | ★ N/A |
| Revenue Growth | 11.90 | ★ 550.00 |
| 52 Week Low | $12.79 | $26.19 |
| 52 Week High | $25.50 | $155.29 |
Technical Indicators
Market Signals| Indicator | TWIN | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 54.13 | 51.54 |
| Support Level | $21.86 | $70.23 |
| Resistance Level | $24.28 | $131.01 |
| Average True Range (ATR) | 1.13 | 10.16 |
| MACD | 0.06 | -1.30 |
| Stochastic Oscillator | 63.10 | 43.91 |
Price Performance
Historical ComparisonAbout TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.